A detailed history of Bank Of New Hampshire transactions in Dexcom Inc stock. As of the latest transaction made, Bank Of New Hampshire holds 12,461 shares of DXCM stock, worth $997,378. This represents 0.21% of its overall portfolio holdings.

Number of Shares
12,461
Previous 11,653 6.93%
Holding current value
$997,378
Previous $1.32 Million 36.79%
% of portfolio
0.21%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$64.0 - $116.06 $51,712 - $93,776
808 Added 6.93%
12,461 $835,000
Q2 2024

Jul 01, 2024

BUY
$110.31 - $140.45 $86,152 - $109,691
781 Added 7.18%
11,653 $1.32 Million
Q1 2024

Apr 10, 2024

BUY
$114.22 - $140.1 $1.24 Million - $1.52 Million
10,872 New
10,872 $1.51 Million
Q2 2022

Jul 08, 2022

SELL
$67.99 - $132.89 $2,515 - $4,916
-37 Closed
0 $0
Q1 2022

Apr 20, 2022

BUY
$94.08 - $130.2 $3,480 - $4,817
37 New
37 $19,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.